1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Allergic Diseases
4.2.2 Environmental Pollution
4.3 Market Restraints
4.3.1 Lack of Awareness About Allergic Diseases
4.3.2 Affordability of Allergy Diagnostics
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value in USD)
5.1 By Allergen
5.1.1 Inhaled Allergens
5.1.2 Food Allergens
5.1.3 Other Allergens
5.2 By Product
5.2.1 Instruments
5.2.2 Consumables
5.2.3 Luminometers
5.3 By End-User
5.3.1 Diagnostic Laboratories
5.3.2 Hospitals
5.3.3 Other End-Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 BioMerieux SA
6.1.2 Danaher Corporation
6.1.3 Abionic SA
6.1.4 HOB Biotech Group Corp. Ltd
6.1.5 HYCOR Biomedical
6.1.6 Lincoln Diagnostics Inc.
6.1.7 Omega Diagnostics Group Plc
6.1.8 Siemens Healthineers AG
6.1.9 Stallergenes Greer Ltd
6.1.10 Thermo Fischer Scientific Inc
6.1.11 Revvity Inc. (PerkinElmer Inc.)​
6.1.12 R-Biopharm AG
6.1.13 Immunodiagnostic Systems Holdings PLC (IDS)
6.1.14 Biomeric, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS